Antimony’s critical role in defense has it in high demand globally as geopolitical unrest narratives shift and unfold.
Q3 2025 Management View CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with the expected FDA authorization of GraftAssureDx, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback